Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

View All Information for Patients & Visitors »

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.

Activate Your Account with an access code or Create a New Account

MyHealth for Mobile

The MyHealth mobile app puts all your health information at your fingertips and makes managing your health care simple and quick. Available for iPhone and Android.

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)

Trial ID or NCT#

NCT00402740

Status

NOT RECRUITING

Purpose

The purpose of this study is to evaluate the long-term safety and efficacy of the Xact™ Rapid Exchange Carotid Stent System used in conjunction with the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5) and the Emboshield® BareWire™ Rapid Exchange Embolic Protection System (Generation 3), in the treatment of atherosclerotic carotid artery disease in high-surgical risk subjects.

Official Title

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years

Sexes Eligible for Study: All

Accepts Healthy Volunteers: No

Investigator(s)

Ronald L. Dalman MD

Vascular surgeon

Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery

Neil Schwartz, MD, PhD

Stroke and vascular neurologist, Neurohospitalist, General neurologist

Clinical Professor, Neurology & Neurological Sciences Clinical Professor (By courtesy), Neurosurgery

Huy M. Do, MD

Interventional neuroradiologist, Radiologist

Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery at the Stanford University Medical Center

CONTACT

Ronald Dalman
(650) 725-5227

SEND MESSAGE

View on ClinicalTrials.gov

New to MyHealth?

MyHealth for Mobile